Showing results (201-210 of 239) with videos related to
Sort By:
Pageof 24
Physical Review Letters|May 21, 2010
Viscous Rayleigh-Taylor instability experiments at high pressure and strain rateHye-Sook Park, K T Lorenz, R M Cavallo, et al.Investigative Radiology|October 1, 1985
Selective occlusion and focal hyperthermia therapy of V-2 tumors in the rabbit hindlimbA W Boddie, K Wright, J W Frazer, et al.Investigative Ophthalmology & Visual Science|July 29, 2003
A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transectionHana Levkovitch-Verbin, Harry A Quigley, Keith R G Martin, et al.American Heart Journal|January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium InvestigatorsR C Becker, S P Ball, P Eisenberg, et al.Experimental Eye Research|May 3, 2005
The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucomaHana Levkovitch-Verbin, Harry A Quigley, Keith R G Martin, et al.American Journal of Surgery|January 1, 1994
Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasmsG M Fuhrman, C Charnsangavej, J L Abbruzzese, et al.Medicine|May 1, 1975
Radiation-related pericardial effusions in patients with Hodgkin's diseaseJ C Ruckdeschel, P Chang, R G Martin, et al.European Journal of Cancer & Clinical Oncology|November 1, 1984
The management of locally advanced breast cancer: a combined modality approachH M Kantarjian, G N Hortobagyi, T L Smith, et al.Journal of Surgical Oncology|September 1, 1987
Proton NMR of human breast tumors: correlation with clinical prognostic parametersD Z Chu, W S Yamanashi, J Frazer, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccineJ M Jessup, C M McBride, F C Ames, et al.Pageof 24